Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Camphene. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| (-)-Camphene SCHEMBL29406765 | 0.98 | CNR2 (0.42) | CNR2 | |
| Camphene SCHEMBL14763794 | 0.98 | CNR2 (0.42) | CNR2 | |
| (-)-Camphene SCHEMBL6552600 | 0.98 | CNR2 (0.42) | CNR2 | |
| Camphene SCHEMBL8921 | 0.98 | CNR2 (0.42) | CNR2 | |
| Camphene SCHEMBL1869438 | 0.98 | CNR2 (0.42) | CNR2 | |
| (-)-Camphene SCHEMBL8819262 | 0.98 | CNR2 (0.42) | CNR2 | |
| Camphene SCHEMBL31305341 | 0.95 | CNR2 (0.41) | CNR2 | |
| Camphene SCHEMBL31057504 | 0.95 | CNR2 (0.41) | CNR2 | |
| Camphene SCHEMBL28998139 | 0.95 | CNR2 (0.41) | CNR2 | |
| Camphene SCHEMBL9803985 | 0.95 | CNR2 (0.41) | CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250198641-A1 | INDOOR AIR CLEANING SYSTEM | MICROJET TECHNOLOGY CO., LTD. (TW) | 2025-06-19 | — | — | US | claimed |
| EP-4571207-A1 | INDOOR AIR CLEANING SYSTEM | Microjet Technology Co., Ltd. (TW) | 2025-06-18 | — | — | EP | claimed |
| CN-120160227-A | Indoor air cleaning system | 研能科技股份有限公司 | 2025-06-17 | — | — | CN | claimed |
| US-20250271158-A1 | INDOOR AIR CLEANING SYSTEM | MICROJET TECHNOLOGY CO., LTD. (TW) | 2025-08-28 | — | — | US | disclosed |
| EP-4607102-A1 | INDOOR AIR CLEANING SYSTEM | Microjet Technology Co., Ltd. (TW) | 2025-08-27 | — | — | EP | disclosed |
| US-20250251157-A1 | INDOOR AIR CLEANING SYSTEM | MICROJET TECHNOLOGY CO., LTD. (TW) | 2025-08-07 | — | — | US | disclosed |
| EP-4596985-A1 | INDOOR AIR CLEANING SYSTEM | Microjet Technology Co., Ltd. (TW) | 2025-08-06 | — | — | EP | disclosed |
| EP-4592606-A1 | INDOOR AIR CLEANING SYSTEM | Microjet Technology Co., Ltd. (TW) | 2025-07-30 | — | — | EP | disclosed |
| US-20250237401-A1 | INDOOR AIR CLEANING METHOD | MICROJET TECHNOLOGY CO., LTD. (TW) | 2025-07-24 | — | — | US | disclosed |
| US-20250237404-A1 | INDOOR AIR CLEANING SYSTEM | MICROJET TECHNOLOGY CO., LTD. (TW) | 2025-07-24 | — | — | US | disclosed |
| EP-4589202-A1 | INDOOR AIR CLEANING METHOD | Microjet Technology Co., Ltd. (TW) | 2025-07-23 | — | — | EP | disclosed |
| US-20040044083-A1 | Exo-S-mecamylamine formulation and use in treatment | UNIVERSITY OF SOUTH FLORIDA | 2004-03-04 | — | — | US | disclosed |
| EP-1139744-A4 | EXO-R-MECAMYLAMINE FORMULATION AND USE IN TREATMENT | UNIV SOUTH FLORIDA (US) | 2003-01-02 | — | — | EP | disclosed |
| EP-1139743-A4 | EXO-S-MECAMYLAMINE FORMULATION AND USE IN TREATMENT | UNIV SOUTH FLORIDA (US) | 2003-01-02 | — | — | EP | disclosed |
| US-20020016371-A1 | Exo-S-mecamylamine or a salt, substantially free of exo-R-mecamylamine in combination with a carrier, useful for treatment of substance addiction | UNIVERSITY OF SOUTH FLORIDA | 2002-02-07 | — | — | US | disclosed |
| US-20020016370-A1 | Exo-R-mecamylamine formulation and use in treatment | UNIVERSITY OF SOUTH FLORIDA | 2002-02-07 | — | — | US | disclosed |
| EP-1139744-A1 | EXO-R-MECAMYLAMINE FORMULATION AND USE IN TREATMENT | UNIVERSITY OF SOUTH FLORIDA (US) | 2001-10-10 | — | — | EP | disclosed |
| EP-1139743-A1 | EXO-S-MECAMYLAMINE FORMULATION AND USE IN TREATMENT | UNIVERSITY OF SOUTH FLORIDA (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000035280-A1 | EXO-R-MECAMYLAMINE FORMULATION AND USE IN TREATMENT | UNIVERSITY OF SOUTH FLORIDA (US) | 2000-06-22 | — | — | WO | disclosed |
| WO-2000035279-A1 | EXO-S-MECAMYLAMINE FORMULATION AND USE IN TREATMENT | UNIVERSITY OF SOUTH FLORIDA (US) | 2000-06-22 | — | — | WO | disclosed |